GH and IGF-1 prevent NAFLD by decreasing visceral fat, reducing lipogenesis in the hepatocytes, and improving fibrosis by inactivating stellate cells [22]. Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.